Schizophrenia research

Reduced higher-dimensional resting state fMRI dynamism in clinical high-risk individuals for schizophrenia identified by meta-state analysis.

Schizophrenia research

Mennigen E, Miller RL, Rashid B, Fryer SL, Loewy RL, Stuart BK, Mathalon DH, Calhoun VD

Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.

Schizophrenia research

Nakahara S, Medland S, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Vaidya JG, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, van Erp TGM

Childhood trauma and clinical high risk for psychosis.

Schizophrenia research

Loewy RL, Corey S, Amirfathi F, Dabit S, Fulford D, Pearson R, Hua JPY, Schlosser D, Stuart BK, Mathalon DH, Vinogradov S

Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

Schizophrenia research

Davidson CA, Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW, Johannesen JK

Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia.

Schizophrenia research

Hare SM, Law AS, Ford JM, Mathalon DH, Ahmadi A, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA

Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.

Schizophrenia research

Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF

Exploration of clinical high-risk dropouts.

Schizophrenia research

Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J

Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.

Schizophrenia research

Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH

Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.

Schizophrenia research

Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J

Comorbid diagnoses for youth at clinical high risk of psychosis.

Schizophrenia research

Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW

Pages